Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Vasodilator Therapy of Cardiac Failure
Jan Koch-Weser
, Jay N Cohn
, Joseph A. Franciosa
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
191
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vasodilator Therapy of Cardiac Failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myocardial Infarction
100%
Cardiac Failure
100%
Vasodilator Therapy
100%
Left Ventricular Dysfunction
66%
Pump Function
66%
Myocardial Ischemia
33%
Lung
33%
Clinical Signs
33%
Left Ventricle
33%
Filling Pressure
33%
Left Ventricular End-diastolic Pressure (LVEDP)
33%
High Filling
33%
Hemodynamic Derangements
33%
Medicine and Dentistry
Acute Heart Infarction
100%
Myocardial Infarction
100%
Congestive Heart Failure
100%
Heart Left Ventricle Failure
66%
Apoplexy
33%
Lung
33%
Heart Muscle Ischemia
33%
Hemodynamic
33%
Left Ventricle
33%
Heart Ventricle Enddiastolic Pressure
33%
Nursing and Health Professions
Congestive Heart Failure
100%
Acute Heart Infarction
100%
Heart Left Ventricle Failure
66%
Cerebrovascular Accident
33%
Heart Muscle Ischemia
33%
Heart Ventricle Enddiastolic Pressure
33%
Hemodynamic
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Congestive Heart Failure
100%
Heart Left Ventricle Failure
66%
Cerebrovascular Accident
33%
Heart Muscle Ischemia
33%